Transforming Medicines Manufacturing

Innovate UK’s Medicines Manufacturing programmes aim to drive the de-risking and adoption of highly innovative flexible, agile and scalable manufacturing technologies through a culture of collaboration that will drive the growth of this critically important manufacturing sector.

About the programme

The Transforming Medicines Manufacturing (TMM) programme leads on from the ISCF Medicines Manufacturing Challenge Community, which was established in 2017 and ran until 2022, and has been designed to support and grow the UK’s capabilities in manufacturing medicines by developing first-of-a-kind technologies to accelerate patient access to new drugs and treatments.

TMM consists of a range of funding competitions as well as a Community of Practice which will include a range of face-to-face events, interactive workshops and webinars amongst other activities.

Programme objectives

  • De-risk the use of technologies in innovative manufacturing.
  • Drive disruptive technology innovation of long-term strategic importance.
  • Build resilience and growth in the medicines manufacturing sector ensuring health security and patient benefit.
  • Support economic recovery and levelling up through supporting job creation, skills development and encouraging inward investment.
  • Supporting ambitious ED&I goals across the sector to establish a culture of change.
  • Address the Net Zero agenda and sustainability goals through funding novel manufacturing technologies to improve yields reduce waste and cut emissions.

Transforming Medicines Manufacturing introduction

The key to the UK’s future as a global medicines manufacturing hub is its people. The Medicines Manufacturing Challenge has laid the groundwork for building this highly skilled workforce, but we need to continue to nurture the pipeline for the next generation of scientists, engineers and technicians to maintain a thriving industry.

Focus Areas

Nucleic Acid Medicines Manufacturing

FOCUS AREA

Nucleic Acid Medicines Manufacturing

Improving the resource efficiency, productivity, and scalability for the manufacture of nucleic acid medicines.

Digitalisation and automation

FOCUS AREA

Digitalisation and automation

Driving digitalisation and automation technologies in the development and manufacture of medicines.

Intracellular drug delivery

FOCUS AREA

Intracellular drug delivery

Development and manufacturing of innovative formulations for DNA and RNA-based medicines.

Flexible, Agile, Sustainable, Scalable Technologies

FOCUS AREA

Flexible, Agile, Sustainable, Scalable Technologies

Investing in advanced manufacturing technologies for better, more responsive manufacturing approaches.

Simplified Delivery of Complex Medicines

FOCUS AREA

Simplified Delivery of Complex Medicines

Accelerating innovation in complex medicines formulation, manufacturing, and delivery.


The Community of Practice

A collaborative forum, bringing together key stakeholders to drive forward cutting-edge innovation in medicines manufacturing in the UK.

Read more

Our Experts

Related Opportunities

Flexible, agile, scalable and sustainable medicines manufacturing

Opens: 26/09/2023 Closes: 22/11/2023

UK registered organisations can apply for a share of up to £5m for development and implementation of technologies for medicines development and manufacture.

More Information

Canada-UK: Biomanufacturing of Biologics and Advanced Therapies

Opens: 26/06/2023 Closes: 17/10/2023

UK registered organisations can apply for a share of up to £3.5m to collaborate with Canadian SMEs on joint R&D to innovate in biomanufacturing biologics and advanced therapies.

More Information

Innovate UK innovation loans future economy: round 11

Opens: 14/09/2023 Closes: 08/11/2023

UK registered businesses can apply for loans for innovative projects with strong commercial potential to significantly improve the UK economy.

More Information

Related News

Help us shape the future of innovation!

11/07/2023

Help us shape the future of innovation!

Innovate UK is looking to expand their assessor pool to review applications in the Health and Life Sciences area. Join us and be part of a vibrant community of experts dedicated to driving innovation forward.

Read more
Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK

02/05/2023

Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK

We are pleased to announce our pilot accelerators, in collaboration with the Medical Research Council (MRC), which will allow spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from the innovation ecosystem.

Read more
More News

Join the community

Join the medicines manufacturing community of practice to stay up to date with the latest news, grant funding, policy changes and regulatory announcements. Interact and collaborate with other organisations and help shape the future of medicines manufacturing in the UK.

Close

Connect with Innovate UK KTN

Join Innovate UK KTN's mailing list to receive updates on funding opportunities, events and to access IUK KTN’s deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.